国家: 英国
语言: 英文
来源: VMD (Veterinary Medicines Directorate)
Phenobarbital
Vetoquinol UK Ltd
Phenobarbital
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Neurological Agent antiepileptic
Authorized
1996-04-11
Revised: December 2022 AN: 01687/2022 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Epiphen 60 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: 60 mg of Phenobarbital per tablet For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet White, circular bioconvex tablet with stamp ‘60’ on surface. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Phenobarbital is an antiepileptic agent for use in the control of epilepsy in the dog. 4.3 CONTRA-INDICATIONS Not for use in pregnant animals. Do not administer to animals with impaired hepatic function. Do not use in cases of hypersensitivity to the active substance(s), to any other barbiturates or to any of the excipients Do not use in animals with serious renal and/or cardiovascular/respiratory disorders. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The decision to start antiepileptic drug therapy with phenobarbital should be evaluated for each individual case and depends on number, frequency, duration and severity of seizures in dogs. To achieve successful therapy, administration of tablets should occur at the same time(s) each day and should be co-ordinated with feeding times in a consistent manner. Revised: December 2022 AN: 01687/2022 Page 2 of 8 Withdrawal or transition from other types of antiepileptic therapy should be made gradually to avoid precipitating an increase in the frequency of seizures. Some dogs are free of epileptic seizures during the treatment, but some dogs show only a seizure reduction, and some dogs are considered to be non- responders. 4.5 SPECIAL PRECAUTIONS FOR USE i. SPECIAL PRECAUTIONS FOR USE IN ANIMALS Caution is recommended in animals with: - impaired hepatic and renal function - hypovolemia, anaemia and - cardiac or respiratory dysfunction The chance of hepatotoxic side effects can be diminished or delayed using an effective dose that is as low as possible. Monitoring of hepatic parameters is r 阅读完整的文件